about
Enzymatic and non-enzymatic isolation systems for adipose tissue-derived cells: current state of the art.Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164In toto differentiation of human amniotic membrane towards the Schwann cell lineage.Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS).VEGF released from a fibrin biomatrix increases VEGFR-2 expression and improves early outcome after ischaemia-reperfusion injury.Salamanders on the bench - A biocompatibility study of salamander skin secretions in cell cultures.Secreted microvesicular miR-31 inhibits osteogenic differentiation of mesenchymal stem cells.Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications.Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table.Extracorporeal shock wave therapy in situ - a novel approach to obtain an activated fat graft.A novel bioreactor for the generation of highly aligned 3D skeletal muscle-like constructs through orientation of fibrin via application of static strain.A Luciferase-Based Quick Potency Assay to Predict Chondrogenic Differentiation.Evaluation of a thermoresponsive polycaprolactone scaffold for in vitro three-dimensional stem cell differentiation.Effects of amniotic epithelial cell transplantation in endothelial injury.Telomerase immortalized human amnion- and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics.Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model.Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells.Organized development from human embryonic stem cells after injection into immunodeficient mice.A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.Human amniotic membrane as newly identified source of amniotic fluid pulmonary surfactantA novel experimental rat model of peripheral nerve scarring that reliably mimics post-surgical complications and recurring adhesions.A Noninvasive In Vitro Monitoring System Reporting Skeletal Muscle Differentiation.Isolation of pig bone marrow mesenchymal stem cells suitable for one-step procedures in chondrogenic regeneration.Three specific antigens to isolate endothelial progenitor cells from human liposuction material.Thrombin as important factor for cutaneous wound healing: comparison of fibrin biomatrices in vitro and in a rat excisional wound healing model.Different metabolic activity in placental and reflected regions of the human amniotic membrane.Gelatin embedding for the preparation of thermoreversible or delicate scaffolds for histological analysis.Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro.Hydrogel composition and laser micropatterning to regulate sciatic nerve regeneration.Transplantation of human amnion prevents recurring adhesions and ameliorates fibrosis in a rat model of sciatic nerve scarring.Secretome Conveys the Protective Effects of ASCs: Therapeutic Potential Following Hemorrhagic Shock?Improvement of adipose tissue-derived cells by low-energy extracorporeal shock wave therapy.Non-invasive in vivo tracking of fibrin degradation by fluorescence imaging.An in vitro model of mesenchymal stem cell targeting using magnetic particle labelling.Systematic Comparison of Protocols for the Preparation of Human Articular Cartilage for Use as Scaffold Material in Cartilage Tissue Engineering.The adipose tissue-derived stromal vascular fraction cells from lipedema patients: Are they different?In vitro extracorporeal shock wave treatment enhances stemness and preserves multipotency of rat and human adipose-derived stem cells.Human platelet lysate is a feasible candidate to replace fetal calf serum as medium supplement for blood vascular and lymphatic endothelial cells.Human mesenchymal stem cells and renal tubular epithelial cells differentially influence monocyte-derived dendritic cell differentiation and maturation.Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue.
P50
Q30401607-11710F8E-E205-4552-A1C1-74F61422BDA6Q33627325-40C7D760-3204-4767-97CF-AC42880C212DQ34380694-2102858B-B8B4-4D75-BEEA-70770C05D08EQ35624272-5316000C-1320-4965-A34E-8B79E522883BQ35896387-ABF759EF-821F-437C-B6F0-3C69FEAE1432Q36383477-6786C4E6-84FE-4B8B-93A6-C57E191BD366Q37066995-B08730EA-D11C-4C2A-9EC1-A11E4B6F9CE9Q37512295-97B9D457-0437-4173-88C3-E33D179F15E0Q37641341-E65D3A26-B713-4383-886D-99186AE87B12Q38685925-5E23A8DD-90D9-4D4C-83B4-E79E57CEBA26Q38856898-11097373-3588-41E4-BA93-61FACF35C704Q38889520-91349A8E-EF17-4736-94DF-015CCA9B8854Q38962124-EA9E9BE8-A619-400B-A3E4-BD5A09D693A8Q39127466-7EE7132A-CFB8-499E-9BFA-B7A39EE2EAA9Q39898293-EA0EC540-76C3-4400-9AA5-94D6335F65E0Q40059303-4CC01293-3110-4CAC-B70F-4D343BD9DE59Q40442597-2AEE99DE-AD34-42C2-8BCB-5839112F2F8BQ40519575-C9CA8722-4B92-451A-BA02-A2E46EE00671Q40757568-EFEA6940-9148-4F07-8B09-29606AD32053Q41124871-8C7B1339-281C-40B8-8006-AB09D3A8BB0FQ41440539-EA451EE5-DB01-4326-9F26-4950FCD56C4FQ42502432-D3B818D1-F787-40F1-A768-E73CD541188DQ44016008-75D3174D-5380-4C11-BD11-BCFA758F4D92Q44691187-4028CDE3-BE23-48CD-9F7D-4D9DB3D46345Q45130928-7FCDFF09-27CB-48FB-8A32-77E025A3BF33Q46667032-692BFC8C-7BB1-4800-A894-7417E3F2CC73Q46869572-10E85EC2-7B6D-4BAE-B394-4886BF77FD10Q47252876-EAAA2488-F09C-4C0E-8636-14335C1975BCQ47387171-749DD334-DF59-49E0-9AC4-6C325B78E48AQ47571023-46562B7B-567E-485E-950D-AEEFA3A36A4EQ47641486-1EF2471D-4C17-42CA-9DB4-BEAEC0D6D731Q47892590-AD8A2922-49A6-4149-A049-D72010ED139BQ48289381-C98C1856-0C16-4519-BA97-ABEBCC9322FBQ48743152-4987BBEB-880D-4E01-86D8-71EEF0B6A982Q50194809-243EF218-99CA-44DD-9094-BBCE2CE32BC0Q50209012-8A1D78C5-53F4-441F-A3D1-AA862EC89137Q50461337-E92E4AE1-8DBC-4A79-B843-A4F3946F8747Q50468782-AC2B5EA3-8D5D-4BD4-AC7B-2915F4F8B703Q50552105-056B72F3-09F5-4ED1-B50E-EE5104C204F3Q50693998-18AC82B0-9971-49A6-9A3F-8E26E05537C9
P50
description
researcher
@en
name
Susanne Wolbank
@en
Wolbank S
@nl
type
label
Susanne Wolbank
@en
Wolbank S
@nl
altLabel
Wolbank S
@en
prefLabel
Susanne Wolbank
@en
Wolbank S
@nl
P106
P31
P496
0000-0002-1244-5854